Suppr超能文献

EWGSOP2 低握力切点用于识别肌少症和虚弱表型的性能:老年住院患者的横断面研究。

Performance of the EWGSOP2 Cut-Points of Low Grip Strength for Identifying Sarcopenia and Frailty Phenotype: A Cross-Sectional Study in Older Inpatients.

机构信息

Department of Geriatrics, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.

Medical Faculty, University of Bern, 3012 Bern, Switzerland.

出版信息

Int J Environ Res Public Health. 2021 Mar 28;18(7):3498. doi: 10.3390/ijerph18073498.

Abstract

BACKGROUND

The European Working Group on Sarcopenia has recently proposed revised cut-off values for the definition of low grip strength (EWGSOP2). We therefore compared performance of the EWGSOP2 cut-off definition of low grip strength with other internationally used cut-off points in a sample of older patients.

METHODS

We analyzed geriatric assessment data in a cross-sectional sample of 98 older patients admitted to a post-acute care hospital. First, we compared prevalence of sarcopenia and frailty phenotype in our sample using low grip strength cut-points from the EWGSOP2 and seven other internationally used consensus statements. Second, we calculated correlations between low grip strength and two independent surrogate outcomes (i.e., gait speed, and the clinical frailty scale) for the EWGSOP2 and the other seven cut-point definitions.

RESULTS

Prevalence of sarcopenia based on the EWGSOP2 grip strength cut-off values was significantly lower (10.2%) than five of the seven other cut-point definitions (e.g., 19.4% based on Sarcopenia Definitions and Outcomes Consortium (SDOC) criteria). Similarly, frailty phenotype prevalence was significantly lower based on EWGSOP2 cut-points (57.1%) as compared to SDOC (70.4%). The correlation coefficient of gait speed with low grip strength based on EWGSOP2 cut-points was lower (0.145) as compared to other criteria (e.g., SDOC 0.240).

CONCLUSIONS

Sarcopenia and frailty phenotype were identified considerably less using the EWGSOP2 cut-points for low grip strength, potentially underestimating prevalence of sarcopenia and frailty phenotype in post-acute hospital patients.

摘要

背景

欧洲肌肉减少症工作组最近提出了新的握力降低定义的截断值(EWGSOP2)。因此,我们在一组老年患者中比较了 EWGSOP2 截断定义的握力降低与其他国际上使用的截断点的性能。

方法

我们分析了 98 名入住康复医院的老年患者的老年评估数据。首先,我们使用 EWGSOP2 和其他七个国际共识声明的低握力截断点比较了我们样本中肌少症和衰弱表型的患病率。其次,我们计算了 EWGSOP2 和其他七个截断定义的低握力与两个独立的替代结果(即步态速度和临床虚弱量表)之间的相关性。

结果

基于 EWGSOP2 握力截断值的肌少症患病率明显低于其他七个截断点定义中的五个(例如,基于肌肉减少症定义和结局联合会(SDOC)标准为 19.4%)。同样,基于 EWGSOP2 截断点的衰弱表型患病率也明显低于 SDOC(70.4%)。基于 EWGSOP2 截断点的步态速度与低握力的相关系数较低(0.145),而其他标准(例如,SDOC 为 0.240)。

结论

使用 EWGSOP2 低握力截断值,肌少症和衰弱表型的识别明显减少,可能低估了康复医院患者中肌少症和衰弱表型的患病率。

相似文献

4
Recent sarcopenia definitions-prevalence, agreement and mortality associations among men: Findings from population-based cohorts.
J Cachexia Sarcopenia Muscle. 2023 Feb;14(1):565-575. doi: 10.1002/jcsm.13160. Epub 2023 Jan 5.
6
Sarcopenia definitions and their association with fracture risk in older Swedish women.
J Bone Miner Res. 2024 May 2;39(4):453-461. doi: 10.1093/jbmr/zjae026.
7
Diagnostic and prognostic value of calf circumference for sarcopenia in community-dwelling older adults.
J Nutr Health Aging. 2024 Aug;28(8):100290. doi: 10.1016/j.jnha.2024.100290. Epub 2024 Jun 21.
9
Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition.
Clin Nutr. 2016 Dec;35(6):1557-1563. doi: 10.1016/j.clnu.2016.02.002. Epub 2016 Feb 11.

引用本文的文献

1
3
The role of maximal inspiratory pressure on functional performance in adults with heart failure.
ESC Heart Fail. 2024 Dec;11(6):4231-4241. doi: 10.1002/ehf2.14984. Epub 2024 Aug 19.
9
Grip strength cut-points from the Swiss DO-HEALTH population.
Eur Rev Aging Phys Act. 2023 Aug 5;20(1):13. doi: 10.1186/s11556-023-00323-6.

本文引用的文献

1
Sarcopenia in hospitalized geriatric patients: insights into prevalence and associated parameters using new EWGSOP2 guidelines.
Eur J Clin Nutr. 2021 Apr;75(4):653-660. doi: 10.1038/s41430-020-00780-7. Epub 2020 Oct 15.
2
A scoping review of the Clinical Frailty Scale.
BMC Geriatr. 2020 Oct 7;20(1):393. doi: 10.1186/s12877-020-01801-7.
4
Identification of Sarcopenia Components That Discriminate Slow Walking Speed: A Pooled Data Analysis.
J Am Geriatr Soc. 2020 Jul;68(7):1419-1428. doi: 10.1111/jgs.16524. Epub 2020 Jul 7.
5
Sarcopenia Definition & Outcomes Consortium Defined Low Grip Strength in Two Cross-Sectional, Population-Based Cohorts.
J Am Geriatr Soc. 2020 Jul;68(7):1438-1444. doi: 10.1111/jgs.16419. Epub 2020 Jul 7.
6
Putative Cut-Points in Sarcopenia Components and Incident Adverse Health Outcomes: An SDOC Analysis.
J Am Geriatr Soc. 2020 Jul;68(7):1429-1437. doi: 10.1111/jgs.16517. Epub 2020 Jul 7.
7
Impact of using the updated EWGSOP2 definition in diagnosing sarcopenia: A clinical perspective.
Arch Gerontol Geriatr. 2020 Sep-Oct;90:104125. doi: 10.1016/j.archger.2020.104125. Epub 2020 May 23.
8
Effect of testing procedures on gait speed measurement: A systematic review.
PLoS One. 2020 Jun 1;15(6):e0234200. doi: 10.1371/journal.pone.0234200. eCollection 2020.
9
Sarcopenia Definition: The Position Statements of the Sarcopenia Definition and Outcomes Consortium.
J Am Geriatr Soc. 2020 Jul;68(7):1410-1418. doi: 10.1111/jgs.16372. Epub 2020 Mar 9.
10
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment.
J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2. doi: 10.1016/j.jamda.2019.12.012. Epub 2020 Feb 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验